nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease
|
Ibrahim, Uroosa |
|
|
23 |
10 |
p. 772-778 |
artikel |
2 |
Cross-Study Comparisons of JAK2 Inhibitors in Myelofibrosis: Risks and Recommendations
|
Mascarenhas, John |
|
|
23 |
10 |
p. 714-718 |
artikel |
3 |
Editorial Board
|
|
|
|
23 |
10 |
p. A4-A5 |
artikel |
4 |
Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary
|
Lewis, Ellen |
|
|
23 |
10 |
p. e331-e334 |
artikel |
5 |
Factors Influencing Physician Discretion to Administer CNS Prophylaxis in Diffuse Large B Cell Lymphoma: A Single Institution Retrospective Study
|
Hino, Christopher |
|
|
23 |
10 |
p. 764-771 |
artikel |
6 |
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy
|
Lutfi, Forat |
|
|
23 |
10 |
p. 757-763 |
artikel |
7 |
Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis
|
Othman, Tamer |
|
|
23 |
10 |
p. 749-756 |
artikel |
8 |
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis
|
Kawano, Yawara |
|
|
23 |
10 |
p. e360-e367 |
artikel |
9 |
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results
|
Gener-Ricos, Georgina |
|
|
23 |
10 |
p. 742-748 |
artikel |
10 |
Multiple Myeloma in Adolescent and Young Adults: An ASCO CancerLinQ and SEER Analysis
|
Gibson, Steven |
|
|
23 |
10 |
p. e335-e340 |
artikel |
11 |
Real-World Experience With CPX-351 Treatment for Acute Myeloid Leukemia in England: An Analysis From the National Cancer Registration and Analysis Service
|
Legg, Alex |
|
|
23 |
10 |
p. e323-e330 |
artikel |
12 |
Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study
|
Ocio, Enrique M. |
|
|
23 |
10 |
p. e341-e347 |
artikel |
13 |
Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma
|
Giralt, Sergio |
|
|
23 |
10 |
p. 719-732 |
artikel |
14 |
Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis
|
Zhang, Yuhang |
|
|
23 |
10 |
p. 733-741 |
artikel |
15 |
SOHO State of the Art Updates and Next Questions | From Biology to Therapy: Progress in Hodgkin Lymphoma
|
Chohan, Karan L. |
|
|
23 |
10 |
p. 705-713 |
artikel |
16 |
SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
|
Easaw, Saumya |
|
|
23 |
10 |
p. 697-704 |
artikel |
17 |
Table of Contents
|
|
|
|
23 |
10 |
p. A6-A8 |
artikel |
18 |
Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article
|
García-Baztán, Agurne |
|
|
23 |
10 |
p. e348-e359 |
artikel |
19 |
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia
|
Jain, Akriti G. |
|
|
23 |
10 |
p. e315-e322 |
artikel |